Anaplastic Thyroid Cancer
About
Mappings
Therapeutic response
Precision oncology relationships for therapeutic response involving this cancer type.| Type | Biomarker(s) | Cancer type | Therapy(ies) | |
|---|---|---|---|---|
| Sensitivity (+) | BRAF p.V600E | Anaplastic Thyroid Cancer | Dabrafenib, Trametinib | |
| Sensitivity (+) | v::RET | Anaplastic Thyroid Cancer | Selpercatinib | |
| Sensitivity (+) | BRAF p.V600E | Anaplastic Thyroid Cancer | Dabrafenib, Trametinib | |
| Sensitivity (+) | TSC1 oncogenic variants | Anaplastic Thyroid Cancer | Everolimus | |
| Sensitivity (+) | TSC2 oncogenic variants | Anaplastic Thyroid Cancer | Everolimus |